SS Innovations International, Inc. reported strong revenue growth for the fourth quarter and full year of 2025, driven by higher unit sales of the SSi Mantra surgical robotic system.
Revenue for the fourth quarter of 2025 reached approximately $15.0 million, marking an 85% increase from the same period in 2024.
Full-year 2025 revenue totaled about $43.0 million, representing a significant 108% surge from the previous year.
Revenue Growth
Quarterly revenue soared by 85% to $15.0 million, and annual revenue rose by 108% to $43.0 million.
SSi Mantra Installations
37 installations in Q4 2025, up 68% from Q4 2024; 103 installations in 2025, up 119% from 2024.
Cumulative Installed Base
SSi Mantra cumulative installed base of 168 as of December 31, 2025, up 158% from 2024.
Global Expansion
Focused on democratizing excellence in surgical care globally with pending regulatory approvals in the U.S. and Europe.
- The revenue surge indicates a strong market demand for the SSi Mantra surgical robotic system, highlighting its growing adoption and success in surgical procedures worldwide.
- The company's commitment to affordability and accessibility aligns with the trend towards advanced and cost-effective robotic surgical solutions in the healthcare industry.
SS Innovations International's impressive revenue growth and expansion plans underscore its position as a key player in the surgical robotics industry, poised for further advancements and market penetration.